- In Bloomberg Law, Tom Bulleit Discusses New “Stark” and Anti-Kickback Rules for Value-Based Arrangements (November 25, 2020)
- In Law360, Health Care Attorneys Examine State Drug Pricing Reforms (November 25, 2020)
- In Law360, Health Care Attorneys Address President Trump’s Executive Order on International Reference Pricing for Medicare Drugs (September 29, 2020)
- In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order (September 15, 2020)
- In Law360, Health Care Attorneys Examine Drug Pricing Reforms and Value-Based Pricing (August 3, 2020)
- In Law360, Health Care Attorneys Examine CMS Proposed Rule for Value-Based Purchasing Arrangements (July 10, 2020)
- In Law360, Attorneys Analyze Expanded U.S. Government Scrutiny of Research Compliance (June 26, 2020)
- In CNBC, Megan Bisk Explores Employer Liability from COVID-19 Workplace Lawsuits (June 22, 2020)
- In Science Magazine, Valerie Bonham Addresses NIH Challenges to Distribute COVID-19 Pandemic Research Funds (June 4, 2020)
- In Bloomberg Law, Valerie Bonham Examines University Research Data Cybersecurity Risks (May 21, 2020)
- In Law360, Health Care Attorneys Analyze How to Determine Eligibility for U.S. Health and Human Services COVID-19 Emergency Funds (April 27, 2020)
- In Law360, Health Care Attorneys Examine COVID-19 Actions on Health Workers Staffing Shortage (April 15, 2020)
- In Law360, Tom Bulleit Addresses Impact of COVID-19 Relief Bill on Drug Pricing Legislation (March 30, 2020)
- In Chemical & Engineering News, Valerie Bonham Examines Foreign Influence in Federal Research (March 24, 2020)
- In The Chicago Tribune, Deborah Gersh Addresses Privacy Rules and Coronavirus Patient Identification (March 18, 2020)
- In Report on Medicare Compliance, Valerie Bonham Discusses Increased Scrutiny in Foreign Research Funding (March 3, 2020)
- In Law360, Health Care Attorneys Analyze State Efforts to Regulate Drug Prices and Federal Barriers (February 13, 2020)
- In Law360, Health Care Attorneys Analyze CMS Value-Based Direct Contracting Model (February 5, 2020)
- In National Law Journal, Health Care Attorneys Examine Foreign Influence in Research (February 4, 2020)
- In Law360, Tom Bulleit and Scott Falin Recap 2019 Drug Pricing Initiatives and Look at 2020 (January 15, 2020)
- Modest Drug Pricing Action Looks Likely in 2020 According To Health Care Partner (January 6, 2020)
- In Bloomberg Law, Health Care Attorney Addresses Delay in Harmonizing Human Research Rules (December 16, 2019)
- Valerie Bonham Appointed to National Academy of Sciences’ Board on Life Sciences (December 10, 2019)
- In The New York Times, Douglas Hallward-Driemeier Examines Hospital Groups Lawsuit to Block Price-Transparency Rule (December 6, 2019)
- In Healthcare Risk Management, Health Care Partner Addresses Proposed “Value-Based” Changes to Stark and Anti-kickback Regulations (November 25, 2019)
- In Healthcare Dive, Health Care Partner Examines Hospital Price Transparency Plan (November 18, 2019)
- In Bloomberg Law, Health Care Partner Examines Stark Law Exemption Impact on Hospitals (October 25, 2019)
- In the American Journal of Clinical Pathology, Health Care Attorney Examines the Use of Tissue in Clinical Trials (October 18, 2019)
- In Inside Health Policy, Health Care Partner Analyzes Proposed Stark Law and Anti-Kickback Statute Reforms (October 18, 2019)
- Ropes & Gray Attorneys to Moderate Webinar on Self-Disclosure for Grant Recipients (October 4, 2019)
- In Law360, Health Care Partner Examines Upcoming Federal Drug Pricing Initiatives (September 4, 2019)
- In Hospital Peer Review, Health Care Partner Examines DOJ’s Compliance Program Evaluation Guidance (September 1, 2019)
- Cross-Practice Attorneys Examine What Self-Disclosure Guidance Means for Federal Research Awardees (August 8, 2019)
- Health Care Partner Discusses Hospital Price Transparency Proposal (August 6, 2019)
- In Bloomberg Law, Health Care Attorneys Examine Expanding Regulatory Oversight of Foreign Influence in Federally Funded Research (July 24, 2019)
- In Bloomberg Law, Health Care Partner Discusses Legal Challenges Facing Trump Administration’s International Drug Pricing Plan (July 15, 2019)
- In Law360, Health Care Partner Addresses Key Takeaways in Drug Pricing Disclosure Ruling (July 12, 2019)
- Valerie H. Bonham, NIH Veteran and Leader in Biomedical Research Compliance and Bioethics, Joins Ropes & Gray as Health Care Counsel (June 25, 2019)
- Health Care Partner Discusses U.S. Senate Health Care Bill and Affordable Care Act Developments in Inside Health Policy and Law360 (June 25, 2019)
- In Law360, Health Care Attorneys Examine New CMS Bundled Payments Program (June 4, 2019)
- In Bloomberg Law, Health Care Partner Examines Final Rule on Drugmaker TV Ad Price Disclosures (May 14, 2019)
- In Law360, Health Care Attorneys Examine Scrutiny of Physician-Owned Distributors (April 29, 2019)
- In Inside Health Policy, Health Care Partner Discusses PBM Drug Rebate Payments Proposal (April 16, 2019)
- Health Care Attorneys Co-Author Article Analyzing New Medicare Bundled Payments Model for Prospective Participants (April 10, 2019)
- In Bloomberg Law, Health Care Partner Addresses Pay-for-Delay Drug Deals (March 13, 2019)
- In Medical Marketing & Media, Attorneys Discuss Drug Pricing Proposals Before Congress (March 5, 2019)
- In Law360, Health Care Attorneys Look at HHS Health Technology Policy Rules (February 25, 2019)
- In Law360, Health Care Attorneys Examine Broader HHS Vision to Innovate Care Models (February 22, 2019)
- In Law360, Health Care Attorneys Look at New HHS Prescription Drug Safe Harbors (February 21, 2019)
- Health Care Partner Discusses HHS Secretary’s First Year in Office (January 31, 2018)
- Outlook 2019 Teleconference: Washington, D.C. Updates and Insights on Life Sciences and Health Care (January 23, 2018)
- In Law360, Cross-Practice Team Analyzes What is New in Federal and State Drug Pricing Initiatives (January 15, 2019)
- Health Care Policy Moves To Watch In 2019 (January 1, 2019)
- In Inside Health Policy, Health Care Partner Discusses Expected Rule on PBM Drug Rebates and Safe Harbors (December 11, 2018)
- Health Care Attorneys Author Law360 Article on CMS Final Medicare Rules for Outpatient Payment Cost-Cutting (November 30, 2018)
- Health Care Partner Appointed to National Institute of Health’s Research Ethics Committee (November 5, 2018)
- Health Care Partner Addresses Medicare Drug Payments (November 1, 2018)
- In Bloomberg Law, Health Care Partner Discusses Data Integrity in Shift to Value-Based Health Care Reimbursement (October 30, 2018)
- Ropes & Gray Health Care Attorneys File Request for Information with HHS Inspector General (October 30, 2018)
- Health Care Co-Chair Discusses HIPAA Audits Focused on Enforcement (October 30, 2018)
- In Law360, Washington, D.C. Partners Analyze CMS’ Drug Price Disclosure Proposal (October 26, 2018)
- Cross-Practice Team Authors “Physician’s Guide to Commercializing a Medical Device Invention” (October 15, 2018)
- In Bloomberg Law, Health Care Attorneys Analyze Proposed Medicare Shared Savings Program Overhaul (September 12, 2018)
- Health Care Partner Examines Changes to HHS Anti-Kickback Statute in Bloomberg Law and Becker’s Hospital Review (September 4, 2018)
- Health Care Partner to Present at Privacy & Security Forum (August 31, 2018)
- Health Care Attorneys Examine Proposed Medicare Shared Savings Program Revisions in Law360 (August 28, 2018)
- Health Care Partner Quoted in Modern Healthcare on Drug Rebates for Pharmacy Benefit Managers (July 19, 2018)
- Health Care Partner Addresses FDA Bid to Lower Drug Prices in The Washington Post (July 19, 2018)
- In Medical Marketing & Media, Life Sciences Partner Addresses Healthcare Marketing Changes Under Trump Administration (May 29, 2018)
- In Law360, Life Sciences Attorneys Examine Lessons From FDA Draft Guidance on Multifunctional Devices (May 23, 2018)
- In Washington Post, Health Care Partner Comments on State Legislation Targeting Drug Pricing Middleman (May 22, 2018)
- In Law360, Cross-Office Team Analyzes President Trump’s Drug Pricing Plan (May 18, 2018)
- Health Care Partner Analyzes President Trump’s Drug Pricing Speech
(May 15, 2018)
- Health Care Partner Moderated Yale Healthcare Conference Panel (May 7, 2018)
- In Law360, Health Care Attorneys Examine How State and Federal Agencies Are Challenging Drug Prices (April 25, 2018)
- Boston Health Care Partner Quoted in Report on Research Compliance Article
(March 21, 2018)
- Health Care Partner to Moderate Yale Healthcare Conference Panel (March 19, 2018)
- Cross-Practice Team Authors Law360 Article on Map for Sharing Health Information Nationwide (February 16, 2018)
- Health Care Attorneys Author Law360 Article on DOJ Guidance Limits in Civil Enforcement Matters (February 12, 2018)
- Event - Outlook 2018 Teleconference: The Trump Administration’s Impact on Life Sciences and Health Care—the First Year (January 23, 2018)
- In Law360, Washington Health Care Partner Addresses Patient Assistance Program Lawsuit (January 12, 2018)
- HHS Office for Civil Rights Releases Research-Related HIPAA Guidance Required by 21st Century Cures Act (January 5, 2018)
- Westlaw JournalsRopes & Gray Attorneys Examine Ransomware Threats in (December 18, 2017)
- In CBS MoneyWatch, Healthcare Partner Quoted on Navigating Obamacare Open Enrollment (December 13, 2017)
- Washington Health Care Partner Authors Ninth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (December 7, 2017)
- In CBS MoneyWatch, Health Care Partner Discusses Navigating Obamacare Open Enrollment (October 30, 2017)
- Health Care Partner Authors Eighth Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter (October 19, 2017)
- Health Care Partner Quoted in Modern Healthcare on States’ Lawsuit to Continue Obamacare Cost-Sharing Payments (October 17, 2017)
-
Health Care Attorneys Author Law360 Article on Future of Value-Based Health Care (October 5, 2017)
- Health Care Partner Quoted in Law360 on Latest Obamacare Repeal Failure(September 26, 2017)
- Health Care Partner Authors Seventh Column on “Repeal and Replace” in Bloomberg BNA’s Health Law Reporter(September 22, 2017)
- Health Care Attorneys Author Law360 Article on Health Care Providers Becoming Payors (September 21, 2017)
- OIG's Warranty Safe Harbor Opinion And Value-Based Care (September 15, 2017)
- “Revisiting the Road Not Taken: Five Alternative Pathways to Regulatory Reform of Obamacare,” Bloomberg BNA’s Health Law Reporter (August 10, 2017)
- What’s Next after a Final(?) Unsuccessful Attempt at Repeal and Replace
(July 28, 2017)
- “Legislative Jenga: Building a Bipartisan Bill to Repair Obamacare,” Bloomberg BNA’s Health Law Reporter (July 19, 2017)
- Statement of Ropes & Gray D.C. Health Group Partner Tom Bulleit on Repeal and Replace
(July 17, 2017)
- Health Care Partner Addresses U.S. Health Care Reform on CBS Radio (June 29, 2017)
- “Searching for Goldilocks: Five Takeaways From the Senate’s Health-Care Reform Porridge-Making,” Bloomberg BNA’s Health Law Reporter (June 22, 2017)
- Health Care Partner Quoted in Law360 on Republican Legislation to Repeal Obamacare (May 30, 2017)
- Statement of Ropes & Gray D.C. Health Group Partner Tom Bulleit on the House’s Passage of the American Health Care Act: AHCA Redivivus, or A Last Gasp? (May 5, 2017)
- “New Frontiers in AMC Funding: Mission Support Alternatives Post-Halifax,” Member Briefing, American Health Lawyers Association (AHLA) AMCs and Teaching Hospitals Practice Group (May 2017)
- Health Care Partner Examines MacArthur Amendment to the American Health Care Act in Bloomberg BNA (April 27, 2017)
- “Failure to Launch the American Health Care Act: Portents for the Future of Health Care Reform?,” Bloomberg BNA’s Health Law Reporter (April 6, 2017)
- Health Care Partner Tom Bulleit's Statement on House Republican Leaders' Pull of Health Care Bill (March 24, 2017)
- “Trump's HHS Moving Fast To Grant Industry Wishes,” Law360 (March 20, 2017)
- “Senate report discourages dealings with physicianowned distributorships,”Compliance Today (March 2017)
- Seminar - A View from Washington of President Trump’s First 60 Days (Recording Available)
- President Trump Announces Health Care Priorities: Repeal/Replace of Obamacare; Tort Reform on Agenda (March 3, 2017)
- “The Price of TrumpCare: Five Takeaways From the HHS Secretary and Other Republican Proposals,” Bloomberg BNA’s Health Law Reporter (February 23, 2017)
- What’s Ahead for Value-Based Health Care? (February 22, 2017)
- Bloomberberg BNA Health Law Reporter Quotes Health Care Partner Mark Barnes on Trump Travel Ban (February 2, 2017)
- Video - Health care in the Trump administration (January 30, 2017)
- Bloomberg BNA Health Law Reporter Quotes Health Care Partner Tom Bulleit on Obamacare Executive Order (January 26, 2017)
- Event - Outlook 2017: The New Administration and Its Impact on Life Sciences and Health Care (January 25, 2017)
- Health Care and FDA Changes Expected Under Trump Administration (January 11, 2017)
- “The New U.S. Department of Health and Human Services: Tom Price and Value-Based Health Care,” JD Supra Business Advisor (January 6, 2017)
- “The New FDA: Product Development, Pricing and Beyond,” JD Supra Business Advisor (January 6, 2017)
- Podcast - The New HHS: Tom Price and Value-Based Healthcare (December 22, 2016)
- Podcast - Enforcement Trends: Health Care Enforcement and False Claims Act (December 20, 2016)
- “GOP Repeal-And-Delay Plans Spell Uncertainty For Insurers,” HealthcareDIVE (December 14, 2016)
- 21st Century Cures Act – Provisions Relating to Development Incentives for Certain Classes of Drugs (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Digital Health (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Reimbursement & Fraud and Abuse (December 13, 2016)
- 21st Century Cures Act – Provisions to Promote Drug Development (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Medical Device Innovation (December 13, 2016)
- 21st Century Cures Act – Provisions Relating to Regulation of Clinical Research (December 13, 2016)
- “Trump Administration Could End Need for ACA Appeal, House Republicans Say,” Bloomberg BNA Health Law Reporter (December 1, 2016)
- MACRA Final Rule and Post-Election Questions (November 28, 2016)
- “Health Care Partner Quoted in Life Sciences Law & Industry News Article on the Obama Administration Trying to Release a Major Revision to the Common Rule Before Inauguration Day,” Bloomberg BNA Life Sciences & Industry Report (November 18, 2016)
- “Obamacare Cases in Limbo Following Republican Wins in White House, Congress,” Bloomberg BNA Health Law Reporter (November 17, 2016)
- Trumping Obamacare: Some Likely Effects of the Election on Health Care (November 10, 2016)
- “Republicans Face Divisions over ObamaCare Repeal,” The Hill (November 13, 2016)
- “How GCs Should Prepare for Trump's ACA Repeal,” Corporate Counsel (November 11, 2016)
- “In Health Care Daily Report, Health Care and Life Sciences Partners Discuss the Drug Pricing Under Trump,” Health Care Daily Report (November 10, 2016)
- “In Law360, Health Care Partner Reacts to Trump's Election To The White House,” Law360 (November 9, 2016)
Cookie Settings
